Late phase II study on setting for concentraion of FK506 (tacrolimus) ointment for atopic dermatitis (No. 2).
- 1 January 1997
- journal article
- Published by Western Japan Division of JDA in The Nishinihon Journal of Dermatology
- Vol. 59 (3) , 427-435
- https://doi.org/10.2336/nishinihonhifu.59.427
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Late phase II study on setting for concentraion of FK506 (tacrolimus) ointment for atopic dermatitis (No. 1).The Nishinihon Journal of Dermatology, 1997
- Chronologic analysis of in situ cytokine expression in mite allergen-induced dermatitis in atopic subjectsJournal of Allergy and Clinical Immunology, 1995
- Analysis of the Cytokine Pattern Expressed In Situ in Inhalant Allergen Patch Test Reactions of Atopic Dermatitis PatientsJournal of Investigative Dermatology, 1995
- Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis.Journal of Clinical Investigation, 1994
- NF-ATp: a transcription factor required for the co-ordinate induction of several cytokine genesImmunology Today, 1994
- Regulation of lnterleukin-5 Production by Peripheral Blood Mononuclear Cells from Atopic Patients with FK506, Cyclosporin A and GlucocorticoidInternational Archives of Allergy and Immunology, 1994